News
Australia’s Main Sequence announces new Partner to spearhead its renewed push for biotech research
Gabrielle will manage the firm’s renewed emphasis on bringing biotechnology (biotech) research to scale in her new role.
Gabrielle will manage the firm’s renewed emphasis on bringing biotechnology (biotech) research to scale in her new role.
On a list of 2013 business buzzwords, ‘innovation’ and ‘disruption’ would surely rank right at the top. With such a pronounced emphasis on both concepts, it was only a matter of time before the role of CID burst onto the scene.
You have reached the end!